Table 1.
Clinical characteristics of patients in the training cohort and validation cohort.
| Training cohort | Validation cohort | P value | |||
|---|---|---|---|---|---|
| N = 333 | N = 166 | ||||
| No. | % | No. | % | ||
| Age | |||||
| ≤60 | 164 | 49.2 | 80 | 48.2 | 0.824 |
| >60 | 169 | 50.8 | 86 | 51.8 | |
| Gender | |||||
| Female | 87 | 26.4 | 46 | 27.7 | 0.706 |
| Male | 246 | 73.9 | 120 | 72.3 | |
| Smoking | |||||
| Former and current smoker | 204 | 61.3 | 110 | 66.3 | 0.276 |
| Nonsmoker | 129 | 38.7 | 56 | 33.7 | |
| HPV status | |||||
| Negative | 53 | 15.9 | 26 | 15.7 | 0.926 |
| Positive | 23 | 6.9 | 10 | 6.0 | |
| Unknown | 257 | 77.2 | 130 | 78.3 | |
| Grade | |||||
| G1-2 | 236 | 70.9 | 123 | 74.1 | 0.749 |
| G3-4 | 84 | 25.2 | 37 | 22.3 | |
| Unknown | 13 | 3.9 | 6 | 3.6 | |
| Stage | |||||
| I | 17 | 5.1 | 8 | 4.8 | 0.888 |
| II | 45 | 13.5 | 24 | 14.5 | |
| III | 56 | 16.8 | 22 | 13.3 | |
| IV | 170 | 51.1 | 89 | 53.6 | |
| Unknown | 45 | 13.5 | 23 | 13.9 | |